http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/medinatura-new-mexico-inc-issues-voluntary-nationwide-recall-reboost-nasal-spray-due-microbial

FDA Approves First Gene Therapy Treatment for Wiskott-Aldrich Syndrome
http://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treatment-wiskott-aldrich-syndrome

http://www.fda.gov/news-events/press-announcements/first-approval-commissioners-national-priority-voucher-pilot-program-strengthens-domestic-antibiotic

FDA Approves First Cellular Therapy to Treat Patients with Severe Aplastic Anemia
http://www.fda.gov/news-events/press-announcements/fda-approves-first-cellular-therapy-treat-patients-severe-aplastic-anemia

FDA Launches TEMPO: A First-of-Its-Kind Digital Health Pilot to Expand Access to Chronic Disease Technologies
http://www.fda.gov/news-events/press-announcements/fda-launches-tempo-first-its-kind-digital-health-pilot-expand-access-chronic-disease-technologies

FDA Approves First CAR T-Cell Therapy for Marginal Zone Lymphoma In the US
http://www.fda.gov/news-events/press-announcements/fda-approves-first-car-t-cell-therapy-marginal-zone-lymphoma-us

FDA Conditionally Approves Topical Drug for Cattle for New World Screwworm and Cattle Fever Tick
http://www.fda.gov/news-events/press-announcements/fda-conditionally-approves-topical-drug-cattle-new-world-screwworm-and-cattle-fever-tick

FDA Announces Leadership Appointments at Center for Drug Evaluation and Research
http://www.fda.gov/news-events/press-announcements/fda-announces-leadership-appointments-center-drug-evaluation-and-research

FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
http://www.fda.gov/news-events/press-announcements/fda-approves-nerve-scaffold-treatment-sensory-nerve-discontinuity

http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/correction-alert-olympus-updates-use-instructions-ligating-device